Chieko Kai
Meguro, 1538505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
Journal: Oncology reports
Published: April 27, 2023
Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
Journal: Scientific reports
Published: October 26, 2022
Gene expression of Nectin-4 and its clinical significance in dogs with primary lung adenocarcinoma.
Journal: Veterinary medicine and science
Published: July 29, 2022
Immune response elicited in the tumor microenvironment upon rMV-SLAMblind cancer virotherapy.
Journal: Cancer science
Published: March 07, 2022
Successful blastocyst production by intracytoplasmic injection of sperm after in vitro maturation of follicular oocytes obtained from immature female squirrel monkeys (Saimiri boliviensis).
Journal: The Journal of reproduction and development
Published: July 12, 2021
The Heterochromatin Block That Functions as a Rod Cell Microlens in Owl Monkeys Formed within a 15-Myr Time Span.
Journal: Genome biology and evolution
Published: January 31, 2021
Comparative genomic analyses illuminate the distinct evolution of megabats within Chiroptera.
Journal: DNA research : an international journal for rapid publication of reports on genes and genomes
Published: June 22, 2020
PIM 3 kinase, a proto-oncogene product, regulates phosphorylation of the measles virus nucleoprotein tail domain at Ser 479 and Ser 510.
Journal: Biochemical and biophysical research communications
Published: May 25, 2020
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.
Journal: Molecular therapy oncolytics
Published: February 07, 2020
Last Updated: 09/26/2026